Table 1.
Treatment of HCV Genotype 1a | |||
LDV/SOF | OBV/PTV/r + DSV + RBV | SOF + SMV ± RBV | |
Treatment duration | 12 weeks | 12 weeks (no cirrhosis) or 24 weeks (cirrhosis) | 12 weeks (no cirrhosis) or 24 weeks (cirrhosis) |
Recommendation level | Class I, level A | Class I, level A | Class IIa, level B |
Treatment of HCV Genotype 1b | |||
LDV/SOF | OBV/PTV/r + DSV* | SOF + SMV | |
Treatment duration | 12 weeks | 12 weeks (no cirrhosis) | 12 weeks (no cirrhosis) or 24 weeks (cirrhosis) |
Recommendation level | Class I, level A | Class I, level A | Class IIa, level B |
DSV = dasabuvir; HCV = hepatitis C virus; LDV = ledipasvir; OBV = ombitasvir; PTV = paritaprevir; r = ritonavir; RBV = ribavirin; SMV = simeprevir; SOF = sofosbuvir
The addition of ribavirin is recommended in patients with cirrhosis.